EISAI INC FDA Approval NDA 206947

NDA 206947

EISAI INC

FDA Drug Application

Application #206947

Documents

Letter2016-04-26
Label2015-02-13
Label2016-05-13
Summary Review2015-03-12
Letter2015-02-17
Letter2016-05-16
Label2016-04-29
Review2015-03-12
Label2017-08-01
Letter2017-08-02
Label2018-06-11
Letter2018-06-14
Label2018-08-16
Letter2018-08-16
Label2018-12-17
Letter2018-12-20
Label2019-09-17
Letter2019-09-18
Letter2020-02-21
Label2020-02-28
Label2020-05-01
Letter2020-05-01
Letter2020-09-16
Label2020-09-21
Letter2020-11-12
Label2020-11-12
Letter2020-12-22
Label2020-12-22
Label2021-07-22
Letter2021-07-22
Label2021-08-11
Letter2021-08-11
Letter2021-12-21
Label2021-12-21
Letter2022-08-08
Label2022-08-08
Label2022-11-13
Letter2022-11-14

Application Sponsors

NDA 206947EISAI INC

Marketing Status

Prescription001
Prescription002

Application Products

001CAPSULE;ORALEQ 4MG BASE1LENVIMALENVATINIB MESYLATE
002CAPSULE;ORALEQ 10MG BASE1LENVIMALENVATINIB MESYLATE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2015-02-13PRIORITY
EFFICACY; EfficacySUPPL3AP2016-05-13PRIORITY
LABELING; LabelingSUPPL4AP2016-04-22STANDARD
LABELING; LabelingSUPPL5AP2017-07-31STANDARD
EFFICACY; EfficacySUPPL7AP2018-08-15STANDARD
LABELING; LabelingSUPPL8AP2018-06-06STANDARD
LABELING; LabelingSUPPL9AP2018-12-07STANDARD
EFFICACY; EfficacySUPPL11AP2019-09-17PRIORITY
LABELING; LabelingSUPPL12AP2020-02-20STANDARD
LABELING; LabelingSUPPL13AP2020-04-23STANDARD
LABELING; LabelingSUPPL16AP2020-11-10STANDARD
LABELING; LabelingSUPPL17AP2020-09-14STANDARD
LABELING; LabelingSUPPL18AP2020-12-18STANDARD
EFFICACY; EfficacySUPPL19AP2021-08-10PRIORITY
EFFICACY; EfficacySUPPL20AP2021-07-21PRIORITY
EFFICACY; EfficacySUPPL21AP2021-12-19STANDARD
LABELING; LabelingSUPPL24AP2022-11-10STANDARD
LABELING; LabelingSUPPL25AP2022-08-05STANDARD

Submissions Property Types

ORIG1Null7
SUPPL3Null6
SUPPL4Null6
SUPPL5Null6
SUPPL7Null7
SUPPL8Null7
SUPPL9Orphan5
SUPPL11Null7
SUPPL12Null7
SUPPL13Null15
SUPPL16Null6
SUPPL17Null7
SUPPL18Null6
SUPPL19Null30
SUPPL20Null6
SUPPL21Null15
SUPPL24Null7
SUPPL25Null6

CDER Filings

EISAI INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206947
            [companyName] => EISAI INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LENVIMA","activeIngredients":"LENVATINIB MESYLATE","strength":"EQ 4MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"No"},{"drugName":"LENVIMA","activeIngredients":"LENVATINIB MESYLATE","strength":"EQ 10MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"09\/14\/2020","submission":"SUPPL-17","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/206947s017lbl.pdf\"}]","notes":""},{"actionDate":"04\/23\/2020","submission":"SUPPL-13","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/206947Orig1s013lbl.pdf\"}]","notes":""},{"actionDate":"02\/20\/2020","submission":"SUPPL-12","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/206947Orig1s012lbl.pdf\"}]","notes":""},{"actionDate":"09\/17\/2019","submission":"SUPPL-11","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/206947s011lbl.pdf\"}]","notes":""},{"actionDate":"12\/07\/2018","submission":"SUPPL-9","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/206947s009lbl.pdf\"}]","notes":""},{"actionDate":"08\/15\/2018","submission":"SUPPL-7","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/206947s007lbl.pdf\"}]","notes":""},{"actionDate":"06\/06\/2018","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/206947s008lbl.pdf\"}]","notes":""},{"actionDate":"07\/31\/2017","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/206947s005lbl.pdf\"}]","notes":""},{"actionDate":"05\/13\/2016","submission":"SUPPL-3","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/206947s003lbl.pdf\"}]","notes":""},{"actionDate":"04\/22\/2016","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/206947s004lbl.pdf\"}]","notes":""},{"actionDate":"02\/13\/2015","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/206947s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"02\/13\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"PRIORITY; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/206947s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/206947Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2015\\\/206947Orig1s000TOC.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2015\\\/206947Orig1s000SumR.pdf\"}]","notes":">"}]
            [supplements] => [{"actionDate":"09\/14\/2020","submission":"SUPPL-17","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/206947s017lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/206947Orig1s017ltr.pdf\"}]","notes":">"},{"actionDate":"04\/23\/2020","submission":"SUPPL-13","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/206947Orig1s013lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/206947Orig1s013ltr.pdf\"}]","notes":">"},{"actionDate":"02\/20\/2020","submission":"SUPPL-12","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/206947Orig1s012lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/206947Orig1s012ltr.pdf\"}]","notes":">"},{"actionDate":"09\/17\/2019","submission":"SUPPL-11","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/206947s011lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/206947Orig1s011ltr.pdf\"}]","notes":">"},{"actionDate":"12\/07\/2018","submission":"SUPPL-9","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/206947s009lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/206947Orig1s009Ltr.pdf\"}]","notes":">"},{"actionDate":"06\/06\/2018","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/206947s008lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/206947Orig1s008ltr.pdf\"}]","notes":">"},{"actionDate":"08\/15\/2018","submission":"SUPPL-7","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/206947s007lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/206947Orig1s007ltr.pdf\"}]","notes":">"},{"actionDate":"07\/31\/2017","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/206947s005lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/206947Orig1s005ltr.pdf\"}]","notes":">"},{"actionDate":"04\/22\/2016","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/206947s004lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/206947Orig1s004ltr.pdf\"}]","notes":">"},{"actionDate":"05\/13\/2016","submission":"SUPPL-3","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/206947s003lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/206947Orig1s003ltr.pdf\"}]","notes":">"},{"actionDate":"10\/16\/2015","submission":"SUPPL-1","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-09-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.